Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Link to SEPIO compliant JSON-LD document

Variant: NM_130839.5(UBE3A):c.582A>G (p.Ala194=)

CA7435619

500854 (ClinVar)

Gene: UBE3A

Condition: Angelman syndrome

Inheritance Mode: Autosomal dominant inheritance

Link to MONDO

UUID: 114ed045-b945-4d58-b23a-5e44edc92e29

Approved on: 2023-06-15

Published on: 2023-06-21

HGVS expressions

NM_130839.5:c.582A>G

NM_130839.5(UBE3A):c.582A>G (p.Ala194=)

NC_000015.10:g.25371592T>C

CM000677.2:g.25371592T>C

NC_000015.9:g.25616739T>C

CM000677.1:g.25616739T>C

NC_000015.8:g.23167832T>C

NG_009268.1:g.72390A>G

ENST00000438097.6:c.522A>G

ENST00000625778.3:c.522A>G

ENST00000635914.1:c.522A>G

ENST00000637886.1:c.582A>G

ENST00000638011.1:c.522A>G

ENST00000638155.1:c.522A>G

ENST00000648336.2:c.582A>G

ENST00000649550.1:c.522A>G

ENST00000650110.1:c.591A>G

ENST00000675000.1:n.1257A>G

ENST00000675177.1:c.405A>G

ENST00000675593.1:n.3278A>G

ENST00000232165.7:c.522A>G

ENST00000397954.6:c.591A>G

ENST00000428984.6:c.522A>G

ENST00000438097.5:c.522A>G

ENST00000566215.5:c.522A>G

ENST00000614096.4:c.582A>G

ENST00000625778.2:c.522A>G

ENST00000626068.2:c.603A>G

ENST00000626793.2:n.633A>G

ENST00000630424.2:c.522A>G

NM_000462.3:c.591A>G

NM_130838.1:c.522A>G

NM_130839.2:c.582A>G

NM_000462.5:c.591A>G

NM_001354505.1:c.582A>G

NM_001354506.1:c.522A>G

NM_001354507.1:c.522A>G

NM_001354508.1:c.522A>G

NM_001354509.1:c.522A>G

NM_001354511.1:c.522A>G

NM_001354512.1:c.522A>G

NM_001354513.1:c.522A>G

NM_001354523.1:c.522A>G

NM_001354526.1:c.522A>G

NM_001354538.1:c.582A>G

NM_001354539.1:c.522A>G

NM_001354540.1:c.522A>G

NM_001354541.1:c.522A>G

NM_001354542.1:c.522A>G

NM_001354543.1:c.522A>G

NM_001354544.1:c.522A>G

NM_001354545.1:c.582A>G

NM_001354546.1:c.405A>G

NM_001354547.1:c.522A>G

NM_001354548.1:c.522A>G

NM_001354549.1:c.522A>G

NM_001354550.1:c.361+3873A>G

NM_001354551.1:c.301+3873A>G

NM_130838.3:c.522A>G

NM_130839.4:c.582A>G

NR_146177.1:n.18393-20004T>C

NR_148916.1:n.1130A>G

NM_001354506.2:c.522A>G

NM_001354507.2:c.522A>G

NM_001354508.2:c.522A>G

NM_001354509.2:c.522A>G

NM_001354511.2:c.522A>G

NM_001354512.2:c.522A>G

NM_001354513.2:c.522A>G

NM_001354523.2:c.522A>G

NM_001354538.2:c.582A>G

NM_001354539.2:c.522A>G

NM_001354540.2:c.522A>G

NM_001354541.2:c.522A>G

NM_001354542.2:c.522A>G

NM_001354543.2:c.522A>G

NM_001354544.2:c.522A>G

NM_001354545.2:c.582A>G

NM_001354546.2:c.405A>G

NM_001354547.2:c.522A>G

NM_001354548.2:c.522A>G

NM_001354549.2:c.522A>G

NM_001354550.2:c.361+3873A>G

NM_001354551.2:c.301+3873A>G

NM_001374461.1:c.522A>G

NM_130838.4:c.522A>G

NR_148916.2:n.1098A>G

Likely Benign

BS1 BP4 BP7

Evidence Links 0

Expert Panel

Rett and Angelman-like Disorders VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Rett and Angelman-like Disorders VCEP

The allele frequency of the c.522A>G p.Ala174= variant in UBE3A (NM_130838.2) is 0.017% in the Latino/Admixed American sub population in gnomAD, which is high enough to meet the BS1 criteria based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). The silent p.Ala174= variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide (BP4, BP7). In summary, the c.522A>G p.Ala174= variant in UBE3A is classified as Likely Benign based on the ACMG/AMP criteria (BS1, BP4, BP7).

BS1

The allele frequency of the c.522A>G p.(Ala174=) variant in UBE3A (NM_130838.2) is 0.017% in the Latino/Admixed American sub population in gnomAD, which is high enough to meet the BS1 criteria based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions.

BP4

The silent p.(Ala174=) variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide.

BP7

The silent p.(Ala174=) variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.